Forecasts suggest that by 2024 the number of digital voice assistants will reach 8.4 billion units – a number higher than the world’s population. However, as these devices are built for commands rather than cognitive testing, how can clinical trials benefit from the technology?

In this webinar, Head of Technology Strategy Nick Taptiklis and Director of Research & Innovation Francesca Cormack, share how they developed and tailored a speech technology platform for clinical trials:

• Adapting automatic speech recognition (ASR) systems for clinical trials
• Delivering useability for the participant
• Automating the administration of well-validated verbal cognitive assessments
• Validating automated scoring against manual methods

Watch the full webinar recording: